AKI

Apr 27, 2026

Summary  AKI continues to be associated with substantial morbidity and mortality, particularly in hospitalized and ICU-based settings where patients often present with severe underlying illness. TERLIVAZ (terlipressin) is the only approved pharmacologic therapy in the broader AKI space, receiving US FDA...

Jan 16, 2025

Acute Kidney Injury is defined as a sudden advent of kidney failure or damage due to the accumulation of waste products in the bloodstream resulting in improper fluid outflow. It is profoundly evident in elderly patients who are hospitalized, especially in intensive care units. The reported incident cases range fro...